What values do the public want their health care systems to use in evaluating technologies?

door Buxton, Martin J., Chambers, James D.
Gepubliceerd in 2011

30 years of media coverage on high drug prices in the US – a never-ending story or a time for change?

door Leopold, Christine, Chambers, James D, Wagner, Anita K
Gepubliceerd in J Pharm Policy Pract (2015)

Variation in health plan specialty drug coverage: an empirical analysis

door Margaretos, Nikoletta M., Lai, Rachel C., Panzer, Ari D., Chambers, James D.
Gepubliceerd in J Drug Assess (2019)

Orphan Drugs Offer Larger Health Gains but Less Favorable Cost-effectiveness than Non-orphan Drugs

door Chambers, James D., Silver, Madison C., Berklein, Flora C., Cohen, Joshua T., Neumann, Peter J.
Gepubliceerd in J Gen Intern Med (2020)

Coverage for Biosimilars vs Reference Products Among US Commercial Health Plans

door Chambers, James D., Lai, Rachel C., Margaretos, Nikoletta M., Panzer, Ari D., Cohen, Joshua T., Neumann, Peter J.
Gepubliceerd in JAMA (2020)

EXAMINING EVIDENCE IN U.S. PAYER COVERAGE POLICIES FOR MULTI-GENE PANELS AND SEQUENCING TESTS

door Chambers, James D., Saret, Cayla J., Anderson, Jordan E., Deverka, Patricia A., Douglas, Michael P., Phillips, Kathryn A.
Gepubliceerd in Int J Technol Assess Health Care (2017)

Payer coverage policies for multigene tests

door Phillips, Kathryn A, Deverka, Patricia A, Trosman, Julia R, Douglas, Michael P, Chambers, James D, Weldon, Christine B, Dervan, Andrew P
Gepubliceerd in Nat Biotechnol (2017)

An Assessment of the Methodological Quality of Published Network Meta-Analyses: A Systematic Review

door Chambers, James D., Naci, Huseyin, Wouters, Olivier J., Pyo, Junhee, Gunjal, Shalak, Kennedy, Ian R., Hoey, Mark G., Winn, Aaron, Neumann, Peter J.
Gepubliceerd in PLoS One (2015)

Correction: An Assessment of the Methodological Quality of Published Network Meta-Analyses: A Systematic Review

door Chambers, James D., Naci, Huseyin, Wouters, Olivier J., Pyo, Junhee, Gunjal, Shalak, Kennedy, Ian R., Hoey, Mark G., Winn, Aaron, Neumann, Peter J.
Gepubliceerd in PLoS One (2015)

How Do Payers Respond to Regulatory Actions? The Case of Bevacizumab

door Dusetzina, Stacie B., Ellis, Shellie, Freedman, Rachel A., Conti, Rena M., Winn, Aaron N., Chambers, James D., Alexander, G. Caleb, Huskamp, Haiden A., Keating, Nancy L.
Gepubliceerd in J Oncol Pract (2015)

Insurance coverage for genomic tests

door Phillips, Kathryn A., Trosman, Julia R., Deverka, Patricia A., Quinn, Bruce, Tunis, Sean, Neumann, Peter J., Chambers, James D., Garrison, Louis P., Douglas, Michael P., Weldon, Christine B.
Gepubliceerd in Science (2018)

The Decline in Vitamin Research Funding: A Missed Opportunity?

door Chambers, James D, Anderson, Jordan E, Salem, Mark N, Bügel, Susanne G, Fenech, Michael, Mason, Joel B, Weber, Peter, West, Keith P, Wilde, Parke, Eggersdorfer, Manfred, Booth, Sarah L
Gepubliceerd in Curr Dev Nutr (2017)